NDC 51672-4074-01 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4074
- Requested NDC
- 51672-4074-01
- Package NDCs from labels
- 51672-4074-5, 51672-4074-7, 51672-4074-1, 51672-4074-2, 51672-4074-6, 51672-4074-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4074-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | CREAM | 15 | 5 | |
| 51672-4074-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | CREAM | 30 | 5 | |
| 51672-4074-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | CREAM | 5 | 5 | |
| 51672-4074-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | CREAM | 45 | 5 | |
| 51672-4074-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | CREAM | 1 | 5 | |
| 51672-4074-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | CREAM | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4074 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4074-1 | GM - Gram | 51672-4074 | e175c1af-8333-4d53-bdc8-9d48bb0de46f | 1 | 2012-07-24 |
| 51672-4074-6 | GM - Gram | 51672-4074 | 4eeceb59-6e4f-4111-8f59-ee88a7b420e9 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GNP Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE, HCL | Amerisource Bergen | b0f0ef97-9add-717f-e053-2a95a90a0eb0 | 2025-10-30 | Warnings | 4T6H12BN9U T5L8T28FGP |
| ChloraPrep One-Step | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | CareFusion 213, LLC | 8529596f-37e4-c44e-e053-2a91aa0ad014 | 2025-10-30 | Warnings | ND2M416302 |
| REMEDY Calazime Skin Protectant | CALAMINE, MENTHOL, WHITE PETROLATUM, ZINC OXIDE | Medline Industries, LP | 1295cfcc-5b61-481b-964b-f53ffd0cb58e | 2025-10-30 | Warnings | 4T6H12BN9U |
| Hemorrhoid Anesthetic | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Universal Distribution Center LLC | 186c2d32-e8c5-d13d-e063-6294a90a2b0e | 2025-10-30 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2025-10-29 | Warnings | PDC6A3C0OX |
| ChloraPrep One-Step | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | CareFusion 213, LLC | 8578da30-a155-2505-e053-2991aa0a2c04 | 2025-10-29 | Warnings | ND2M416302 |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Publix Super Markets Inc | 354a640c-bc7e-45c8-9df0-8b5b01767f5c | 2025-10-29 | Warnings | 4T6H12BN9U PDC6A3C0OX |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2025-10-27 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | PDC6A3C0OX FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | PDC6A3C0OX FZ989GH94E |
| American Red Cross 70% Isopropyl Alcohol | ISOPROPYL ALCOHOL(70%CONC.) | MY IMPORTS USA LLC | 421d7bd9-c893-ec97-e063-6394a90a4b28 | 2025-10-27 | Warnings | ND2M416302 |
| OFTAL-MYCIN LUBRICANT OPHTHALMIC | LIGHT MINERAL, WHITE PETROLATUM | GRANDALL DISTRIBUTING, LLC | 298db04a-21a9-e46e-e063-6294a90acee2 | 2025-10-27 | Warnings | N6K5787QVP |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.